The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

 Bioheart Inc.  (BHRT) Trade Now »     Rate BHRT  -  Discuss BHRT  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate BHRT:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

BHRT: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Bioheart to Introduce Improved Heart Failure Monitoring Systems at Heart Failure Nurses Annual Meeting Graphic_rating_buy BHRT
Foto
62%

SUNRISE, Fla., June 18 /PRNewswire-FirstCall/ -- Bioheart, Inc., (OTC Bulletin Board: BHRT - News ) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced today that the company will be introducing its heart failure monitoring systems at the American Association of Heart Failure Nurses 5th Annual Meeting. This year's meeting will take place from June 25 - 27, 2009 at the Hyatt Regency Minneapolis in Minneapolis, Minnesota.

<> The compact Bioheart 3370 home heart failure ...
By  Marian Filo   (-24.55%  risk: aggressive)  06/19/09 Comment


Bioheart Inc. Graphic_rating_buy BHRT
450vampyr_avatar-med
N/A
Bioheart Reports Year End 2008 Results; Reviews 2008 and 1Q09 Progress and 2009 Business Objectives On Thursday May 7, 2009, 7:00 am EDT SUNRISE, Fla., May 7, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Other OTC:BHRT.PK - News) reports financial results for the year ended December 31, 2008, provides a review of its progress in 2008 and 1Q 2009 and outlines 2009 annual business objectives. Bioheart's Form 10-K was filed on April 15, 2009 and Bioheart's Form 10-K/A was filed on April 30, 2009. Highlights 1Q 2009 * Completed call center set up to support at-home heart failure mo...
By  supratrader   (+16.29%  risk: conservative)  05/10/09 Comment


Stem Cell Index Down 7% in Past Week Graphic_rating_buy BHRT
Mikerun
73%

Stem Cell Index Down 7% in Past Week

<> By Mike Havrilla on 2/15/09

The table at my website link below includes 26 companies in the ETF Innovators Emerging Stem Cell Index, which lost 7% of its market value in the past week (at 1,148 today) and posted a 15.2% loss over the past year on an equal-weight basis.

http://www.etfinnovators.com/2009/02/stem-cell-index-down-7-i...

Results for benchmark indexes and ETFs include gains of 1.5% for the Cosmetic and Restorative Medicine Index and losses of 1.2% for SPDR S&P Biotech (XBI), 18.7% for Healthcare Sector...
By  Mike Havrilla   (+1.04%  risk: conservative)  02/16/09 Comment


Bullish on BHRT ... Graphic_rating_buy BHRT
Foto
62%
Bioheart, Inc. Announces Private Funding Commitments of Up to $7 Million Wednesday February 4, 11:28 am ET SUNRISE, Fla., Feb. 4, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc., (NasdaqCM:BHRT - News) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, announced today that it has entered into a non-binding letter of intent with Organic Business Alliances, LLC (``Organic'') pursuant to which it would invest approximately $1.5 million in Bioheart under its current offering under Regulation D and, subje...
By  Marian Filo   (-24.55%  risk: aggressive)  02/13/09 Comment


Stem Cell Index Down 1% in Past Week Graphic_rating_buy BHRT
Mikerun
73%
Stem Cell Index Down 1% in Past Week
By Mike Havrilla on 2/9/09
ETF Innovators, LLP
 
<> The table at my website link below includes 29 companies in the ETF Innovators (ETFI) Emerging Stem Cell Index, which lost about 1% of market value in the past week and posted an 8.5% loss over the past year on an equal-weight basis. Results for benchmark indexes and ETFs include gains of 1.5% for SPDR S&P Biotech (XBI) and 1.2% for the ETFI Cosmetic and Reconstructive Medicine Index and losses of 17.4% for Healthcare Sector SPDR (XLV), 3.7% for iShares Nasdaq Biotech (IBB), a...
By  Mike Havrilla   (+1.04%  risk: conservative)  02/09/09 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 381
2 Gerald Greene 18.14 +72.34% 210
3 stockmarketfunding.com 17.66 +25.65% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment
YHOO Yahoo! Inc
MO Altria Group Inc
WM Washington Mutual Inc
RIMM Research in Motion Ltd
DRYS DryShips Inc.
GLD streetTRACKS Gold

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on BHRT

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Bioheart Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch